Literature DB >> 17160191

Methodological aspects of Traditional Chinese Medicine (TCM).

Edzard Ernst1.   

Abstract

The efficacy of Traditional Chinese Medicine (TCM) is less well-established than many believe and needs to be more firmly established through clinical trials. Such studies should adhere to the currently accepted standards. When planning and conducting clinical trials, one encounters numerous logistical and methodological problems. The most important logistical obstacle is a lack of funds while the most important methodological issue is to transparently minimise bias. Despite these formidable problems, clinical trials of TCM are usually feasible and certainly necessary for testing the efficacy of TCM.

Mesh:

Year:  2006        PMID: 17160191

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  8 in total

Review 1.  Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.

Authors:  Rolf Teschke; Dominique Larrey; Dieter Melchart; Gaby Danan
Journal:  Medicines (Basel)       Date:  2016-07-19

Review 2.  Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders.

Authors:  Rolf Teschke; Albrecht Wolff; Christian Frenzel; Axel Eickhoff; Johannes Schulze
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

3.  Quality assurance for Chinese herbal formulae: standardization of IBS-20, a 20-herb preparation.

Authors:  Siu-Po Ip; Ming Zhao; Yanfang Xian; Mengli Chen; Yuying Zong; Yung-Wui Tjong; Sam-Hip Tsai; Joseph J Y Sung; Alan Bensoussan; Brian Berman; Harry H S Fong; Chun-Tao Che
Journal:  Chin Med       Date:  2010-02-22       Impact factor: 5.455

Review 4.  Traditional Chinese Medicine Induced Liver Injury.

Authors:  Rolf Teschke
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

Review 5.  Clinical research of traditional chinese medicine needs to develop its own system of core outcome sets.

Authors:  Li Zhang; Junhua Zhang; Jing Chen; Dongmei Xing; Wei Mu; Jiaying Wang; Hongcai Shang
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-07       Impact factor: 2.629

6.  Patient recruitment for clinical trials on traditional Chinese medicine: Challenges, barriers, and strategies.

Authors:  Cheng King-Fai; Leung Ping-Chung; Wong Lai-Yi; Fong Yuet-Shim
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

7.  Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium.

Authors:  Elizabeth H Logue
Journal:  Evid Based Complement Alternat Med       Date:  2008-08-02       Impact factor: 2.629

Review 8.  Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation.

Authors:  Christian Frenzel; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.